Dec 19 (Reuters) - The U.S. Centers for Disease Control and
Prevention (CDC) on Saturday said it was monitoring reports of
allergic reactions to the COVID-19 vaccination and made
recommendations on how people with histories of allergies should
proceed.
Anyone who had a severe reaction to a COVID-19 vaccine
should not get the second dose, the agency said, defining severe
as needing the medication epinephrine or treatment in a
hospital.
People who have had a severe allergic reaction to any
ingredient in a COVID-19 vaccine should avoid the vaccine
formulation containing the ingredient, CDC said. Two vaccines
have been approved in the United States under emergency use
authorizations.
Individuals with histories of severe allergic reaction to
vaccines should consult their doctors about the COVID-19 shot.
The CDC said people with severe allergies to food, pets, latex
or environmental conditions as well as people with allergies to
oral medication or a family history of severe allergic reactions
could still get vaccinated.
The U.S. Food and Drug Administration is investigating
around five allergic reactions that happened after people were
administered Pfizer Inc and BioNTech SE's
COVID-19 vaccine in the United States this week.
On Friday, the FDA said that the Moderna Inc
vaccine, which received emergency use authorization, should not
be given to individuals with a known history of a severe
allergic reaction to any components of the shot.
Britain's medical regulator has said that anyone with a
history of anaphylaxis, or severe allergic reactions to a
medicine or food, should not be given the Pfizer-BioNTech
COVID-19 vaccine.
(Reporting by Kanishka Singh in Bengaluru; Editing by Cynthia
Osterman)
© 2025 Thomson/Reuters. All rights reserved.